Skip to content

APOTHEEK WALRAEVENS

Active
Public limited companyfounded 1996active for 29 yearsNieuwbaan 24, 1742 Ternat, BelgiumKBO/BCE: BE 0459.570.558
Summary

APOTHEEK WALRAEVENS has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €316,255 and a net result of €87,195. Equity remains stable across the filed financial years (±0.1% per year). Its solvency ranks better than 69% of 12,434 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€561,985total assets 2025
Staff
2 FTE
Equity
€316,255
Profit
€87,195
Turnover not published (abbreviated format)
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Parent
THE WALL COMPANY · 99.6%
Accounts 45 days early0 of 5 deeds read
Why 96raises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.10, cash €220,881Founded in 1996Equity €316,255 (56.3% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 69% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 81=
equity 56.3% of total assets
Liquidity 78+6
short-term debt 43.6% · cash 39.3%
Profitability 88-4
return on assets 15.5%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,196 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025highest value 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.1, compared with 2.05 in 2024, above the usual 1.5; short-term debt: 43.6% and cash: 39.3% of total assets), and 43.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 70% on solvency, 83% on liquidity, 83% on profitability and 39% on growth.

The bankruptcy probability was computed on 14-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.10, cash €220,881
NBB · annual accounts
lowers risk · Founded in 1996
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €316,255 (56.3% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-06-2026, 45 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
45 days early
2024
37 days early
2023
22 days early
2022
21 days late
2021
26 days early
2020
31 days late
2019
7 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 5 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
15-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Highest result from 2018 to 2025net €105,322 ▲80.1%

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €87,195 8 years View
  • Controlled by THE WALL COMPANY 99.6% View
  • Active since 1996founded 24-12-1996 29 years View

By topic

Financials

Financial year
2025
Total assets
€561,985
Profit
€87,195
Solvency
56.3%
Total assets▼ 0.5%
Net result
20182025
Go to Financials

Timeline

Events
30
Since
1998
Next accounts
by 31-07-2027
  1. 09-07-2024Annual accounts filed
  2. 21-08-2023Annual accounts filed
  3. 05-07-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
24-12-1996
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.